[K-Startup Weekly News #73] Colosseum Raises $20M to Accelerate AI-Driven Innovation for Global Logistics Platform

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/4c/1e/0e/4c1e0e13-6dad-72ff-31fd-2d7ba951e34c/mza_1030095590937417120.jpg/600x600bb.jpg

Korean Startup News

WOWTALE

40 episodes

1 week ago

WOWTALE, South Korea's dedicated startup media outlet, provides English content covering the vibrant K-Startups landscape—from government policy initiatives and investment rounds for promising early-stage founders to exclusive interviews with innovative Korean Startups and updates from the nation's startup support organizations and venture capital firms.

Business News

News

RSS

All content for Korean Startup News is the property of WOWTALE and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Business News

News

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/43682939/43682939-1750501992494-98ce24980476e.jpg

[K-Startup Weekly News #73] Colosseum Raises $20M to Accelerate AI-Driven Innovation for Global Logistics Platform

Korean Startup News

15 minutes 8 seconds

4 months ago

[K-Startup Weekly News #73] Colosseum Raises $20M to Accelerate AI-Driven Innovation for Global Logistics Platform

https://en.wowtale.net/2025/06/21/231403/

This episode from WOW TALE, a prominent Korean startup media outlet, provides a weekly overview of the Korean startup ecosystem from June 16-22, 2025.

It highlights significant developments, including Colosseum's successful $20.8 million Series B funding round for its AI-driven logistics platform. The report also covers Seoul's rise to 8th in the global startup ecosystem rankings and details various other Korean startups securing funding across diverse sectors like parenting, mobility software, K-beauty, e-commerce analytics, premium storage, and restaurant solutions. Finally, the newsletter features interviews with startups aiming for global expansion, such as CrossPoint Therapeutics and SimfliBIO, focusing on biotech innovations.